Monographs & Whitepapers
MRSA Persister Cells and Biofilms: Telavancin’s Role in Therapy
Methicillin-resistant Staphylococcus aureus (MRSA) remains a major driver of difficult-to-treat infections ...
FEBRUARY 23, 2026
2026 Antimicrobial Efficacy
This pocket folder is intended to be a reference to describe the potential in vivo activity of various ...
JANUARY 7, 2026
Plasma Microbial Cell-Free DNA Metagenomic Sequencing for Infectious Disease Diagnosis
Pathogen identification through laboratory testing is a key step during the process of infectious disease ...
SEPTEMBER 26, 2025
Persistent MRSA Bacteremia: Telavancin's Role in Therapy Explored
Staphylococcus aureus bacteremia is one of the most prevalent and serious bacterial infections and is the most ...
AUGUST 29, 2025
Navigating the Global Threat of Typhoid Fever
This Special Report reviews the medical and public health aspects of typhoid and paratyphoid fever, focusing on ...
JULY 28, 2025
The Critical Role of HIV Testing And Reporting in Clinical Practice: Insights From Virology Laboratories
This Special Report discusses the role of viral load testing, the challenges in interpreting results, and best ...
JUNE 27, 2025
Optimizing Management of Invasive Candidiasis With Rezafungin for Injection
This monograph discusses the treatment landscape for candidemia and invasive candidiasis and highlights clinical ...
JUNE 18, 2025
A Targeted Treatment for Carbapenem-Resistant Acinetobacter baumannii
The approval of sulbactam-durlobactam for the treatment of carbapenem-resistant Acinetobacter baumannii infections ...
APRIL 1, 2025
Antimicrobial Efficacy
This pocket folder is intended to be a reference to describe the potential in vivo activity of various ...
MARCH 24, 2025
The Importance of Biofilm Penetration: A Review of Telavancin
Biofilm formation in prosthetic joint infections (PJIs) enhances bacterial resistance to conventional therapies. ...
MARCH 4, 2025
The Role of Local Laboratories in HIV and HCV Diagnosis and Prevention
Learn how local laboratories are providing testing services for HIV and HCV and about the significant progress and ...
OCTOBER 4, 2024
Use of Dalbavancin in Optimizing the Management of ABSSSIs in Patients With Obesity or Diabetes
This Special Report reviews data on the use of dalbavancin for the treatment of ABSSSIs to support safety and ...
JULY 9, 2024
